ABL DIAGNOSTICS (EPA:ABLD) | Finanzwire

Basculer en Français

10603	Companies
225009	Keywords
153732	Articles
119071	Press releases

Home
Companies
ABL DIAGNOSTICS

BRIEF

published on 06/18/2026 at 13:57, 2 days 4 hours ago

ABL Diagnostics: Growth and Outlook for 2026

INVEST SECURITIES Growth Partnerships Molecular Diagnosis Genotyping
BRIEF

published on 06/18/2026 at 13:57, 2 days 4 hours ago

ABL Diagnostics Projects Notable Growth and Upward Potential

Strategic Partnerships Revenue Increase Buy Recommendation ABL Diagnostics Growth 2026
PRESS RELEASE

published on 06/18/2026 at 13:52, 2 days 4 hours ago

Inside Information / Other news releases
ABL Diagnostics confirms growth trajectory with strong upside potential. Invest Securities raises target price to €8.7 and maintains 'Buy' recommendation

INVEST SECURITIES Target Price Growth Trajectory Upside Potential ABL Diagnostics
BRIEF

published on 06/12/2026 at 08:05, 8 days 10 hours ago

ABL Diagnostics and CDL Pharma sign a €2.7 million contract until 2031

Clinical Trials Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma
BRIEF

published on 06/12/2026 at 08:05, 8 days 10 hours ago

ABL Diagnostics and CDL Pharma Secure €2.7 Million Contract

Clinical Program Neurodegenerative Diseases International Contract ABL Diagnostics CDL Pharma
PRESS RELEASE

published on 06/12/2026 at 08:00, 8 days 10 hours ago

Inside Information / Other news releases
ABL Diagnostics and CDL Pharma secure a multi-year international contract of up to €2.7 million through 2031. The contract involves services for neurodegenerative disease clinical programs across North America, Europe, and Asia

Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma International Clinical Program
BRIEF

published on 06/10/2026 at 00:05, 10 days 18 hours ago

ABL Diagnostics Discloses Voting and Share Information

Euronext Paris Share Capital Voting Rights Molecular Biology Double Voting
BRIEF

published on 06/10/2026 at 00:05, 10 days 18 hours ago

ABL Diagnostics: Information on voting rights and capital

Euronext Paris Voting Rights Registered Shares Molecular Biology ABL Share Capital
PRESS RELEASE

published on 06/10/2026 at 00:00, 10 days 18 hours ago

Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers

Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
BRIEF

published on 06/09/2026 at 19:05, 10 days 23 hours ago

ABL Diagnostics is preparing for its General Assembly on June 30, 2026

Investors General Assembly Preparatory Documents Molecular Biology ABL Diagnostics

Accesswire

Published on 06/20/2026 at 01:00, 17 hours 34 minutes ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 18 hours 34 minutes ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 14 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 17 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 17 hours ago

Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting

View all ACCESSWIRE

EQS Group

Published on 06/20/2026 at 06:00, 12 hours 34 minutes ago

Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 22 hours 16 minutes ago

2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 19:01, 23 hours 33 minutes ago

Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 18:29, 1 day ago

Designated Person Notification
Published on 06/19/2026 at 18:00, 1 day ago

Successful issue of a CHF 100 million green bond

Les Echos

Published on 06/19/2026 at 19:33, 23 hours 1 minute ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 23 hours 10 minutes ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/18/2026 at 18:00, 2 days ago

Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 2 days ago

EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 2 days ago

Statement of transactions in own shares from June 8, 2026 to June 12, 2026

View all LES ECHOS COMFI WIRE